An inability of the human body to heal acute wounds under certain conditions results in the formation of chronic ulcers. Chronic wounds not only cause significant pain and discomfort for patients but also serve as an entry for microorganisms into the human body, which can result in serious life-threatening problems and become a significant burden for the patients and society. The current work present results of a multicentre prospective observational study demonstrating the use of a lyophilized amniotic membrane (AM) in the treatment of chronic wounds (various etiologies). Lyophilized AM produced under the commercial brand Amnioderm® was used as an allograft material for therapy of chronic wounds, in addition to chronic ulcer standard-of-care (SoC) protocols. The duration of wounds considered for the application of AM ranged between 2 months and 11 years. In total, 16 patients were enrolled to the study, of which eight were completely healed, six demonstrated a significantly reduced ulcer size, and two did not respond to the AM therapy. The current study unambiguously demonstrates an effective alternative to the standard of chronic wound care and confirms a significant effect of the AM application for chronic wound management as a new SoC.

BioHealing Brno Czechia

Department of Burns and Plastic Surgery Faculty of Medicine Institution Shared With University Hospital Brno Masaryk University Brno Czechia

PrimeCell Bioscience Inc Ostrava Czechia

Zobrazit více v PubMed

Bianchi C., Cazzell S., Vayser D., Reyzelman A. M., Dosluoglu H., Tovmassian G., et al. . (2018). A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix((R))) allograft for the treatment of venous leg ulcers. Int. Wound J. 15, 114–122. 10.1111/iwj.12843 PubMed DOI PMC

Castellanos G., Bernabe-Garcia A., Moraleda J. M., Nicolas F. J. (2017). Amniotic membrane application for the healing of chronic wounds and ulcers. Placenta 59, 146–153. 10.1016/j.placenta.2017.04.005 PubMed DOI

Cirman T., Beltram M., Schollmayer P., Rozman P., Kreft M. E. (2014). Amniotic membrane properties and current practice of amniotic membrane use in ophthalmology in Slovenia. Cell Tissue Bank 15, 177–192. 10.1007/s10561-013-9417-6 PubMed DOI

Davis J. S. (1909). II. Skin grafting at the Johns Hopkins Hospital. Ann. Surg. 50, 542–549. 10.1097/00000658-190909000-00002 PubMed DOI PMC

de Rotth A. (1940). Plastic repair of conjunctival defects with fetal membranes. Arch. Ophthalmol. 23:522e525. 10.1001/archopht.1940.00860130586006 DOI

Diaz-Prado S., Muinos-Lopez E., Hermida-Gomez T., Cicione C., Rendal-Vazquez M. E., Fuentes-Boquete I., et al. . (2011). Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation 81, 162–171. 10.1016/j.diff.2011.01.005 PubMed DOI

Didomenico L. A., Orgill D. P., Galiano R. D., Serena T. E., Carter M. J., Kaufman J. P., et al. . (2018). Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients. Int. Wound J. 15, 950–957. 10.1111/iwj.12954 PubMed DOI PMC

Elheneidy H., Omran E., Halwagy A., Al-Inany H., Al-Ansary M., Gad A. (2016). Amniotic membrane can be a valid source for wound healing. Int. J. Womens Health 8, 225–231. 10.2147/IJWH.S96636 PubMed DOI PMC

Faulk W. P., Matthews R., Stevens P. J., Bennett J. P., Burgos H., Hsi B. L. (1980). Human amnion as an adjunct in wound healing. Lancet 1, 1156–1158. 10.1016/S0140-6736(80)91617-7 PubMed DOI

Forbes J., Fetterolf D. E. (2012). Dehydrated amniotic membrane allografts for the treatment of chronic wounds: a case series. J. Wound Care 21, 290, 292, 294–296. 10.12968/jowc.2012.21.6.290 PubMed DOI

Grzywocz Z., Pius-Sadowska E., Klos P., Gryzik M., Wasilewska D., Aleksandrowicz B., et al. . (2014). Growth factors and their receptors derived from human amniotic cells in vitro. Folia Histochem. Cytobiol. 52, 163–170. 10.5603/FHC.2014.0019 PubMed DOI

Insausti C. L., Alcaraz A., Garcia-Vizcaino E. M., Mrowiec A., Lopez-Martinez M. C., Blanquer M., et al. . (2010). Amniotic membrane induces epithelialization in massive posttraumatic wounds. Wound Repair. Regen. 18, 368–377. 10.1111/j.1524-475X.2010.00604.x PubMed DOI

Iranpour S., Mahdavi-Shahri N., Miri R., Hasanzadeh H., Bidkhori H. R., Naderi-Meshkin H., et al. . (2018). Supportive properties of basement membrane layer of human amniotic membrane enable development of tissue engineering applications. Cell Tissue Bank 19, 357–371. 10.1007/s10561-017-9680-z PubMed DOI

Jarbrink K., Ni G., Sonnergren H., Schmidtchen A., Pang C., Bajpai R., et al. . (2016). Prevalence and incidence of chronic wounds and related complications: a protocol for a systematic review. Syst. Rev. 5:152. 10.1186/s13643-016-0329-y PubMed DOI PMC

John T. (2003). Human amniotic membrane transplantation: past, present, and future. Ophthalmol. Clin. North Am. 16, 43–65. 10.1016/S0896-1549(02)00110-4 PubMed DOI

Kathawala M. H., Ng W. L., Liu D., Naing M. W., Yeong W. Y., Spiller K., et al. . (2019). Healing of chronic wounds - an update of recent developments and future possibilities. Tissue Eng. Part B. Rev. 25, 429–444. 10.1089/ten.teb.2019.0019 PubMed DOI

Kennedy J. B., Larochelle M. B., Pedler M. G., Petrash J. M., Enzenauer R. W. (2018). The effect of amniotic membrane grafting on healing and wound strength after strabismus surgery in a rabbit model. J. AAPOS 22, 22–26 e21. 10.1016/j.jaapos.2017.08.007 PubMed DOI

Klama-Baryla A., Rojczyk E., Kitala D., Labus W., Smetek W., Wilemska-Kucharzewska K., et al. . (2020). Preparation of placental tissue transplants and their application in skin wound healing and chosen skin bullous diseases - Stevens-Johnson syndrome and toxic epidermal necrolysis treatment. Int. Wound J. 17, 491–507. 10.1111/iwj.13305 PubMed DOI PMC

Koizumi N. J., Inatomi T. J., Sotozono C. J., Fullwood N. J., Quantock A. J., Kinoshita S. (2000). Growth factor mRNA and protein in preserved human amniotic membrane. Curr. Eye Res. 20, 173–177. 10.1076/0271-3683(200003)2031-9FT173 PubMed DOI

Koob T. J., Lim J. J., Massee M., Zabek N., Denoziere G. (2014a). Properties of dehydrated human amnion/chorion composite grafts: implications for wound repair and soft tissue regeneration. J. Biomed. Mater. Res. Part B Appl. Biomater. 102, 1353–1362. 10.1002/jbm.b.33141 PubMed DOI

Koob T. J., Lim J. J., Massee M., Zabek N., Rennert R., Gurtner G., et al. . (2014b). Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration. Vasc. Cell 6:10. 10.1186/2045-824X-6-10 PubMed DOI PMC

Koob T. J., Lim J. J., Zabek N., Massee M. (2015). Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing. J. Biomed. Mater. Res. Part B Appl. Biomater. 103, 1133–1140. 10.1002/jbm.b.33265 PubMed DOI

Kubo M., Sonoda Y., Muramatsu R., Usui M. (2001). Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest. Ophthalmol. Vis. Sci. 42, 1539–1546. PubMed

Kuehn B. M. (2007). Chronic wound care guidelines issued. JAMA 297, 938–939. 10.1001/jama.297.9.938 PubMed DOI

Lipovy B., Forostyak S. (2020). Efficacy and safety of newly developed biologic material based on the amniotic membrane in acute burns management. Burns 46, 743–745. 10.1016/j.burns.2019.12.020 PubMed DOI

Lo V., Lara-Corrales I., Stuparich A., Pope E. (2010). Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds. J. Am. Acad. Dermatol. 62, 1038–1044. 10.1016/j.jaad.2009.02.048 PubMed DOI

Macdonald J. (2009). Global Initiative for Wound and Lymphoedema Care (GIWLC). Wounds 5, 172–175.

Mao Y., Hoffman T., Singh-Varma A., Duan-Arnold Y., Moorman M., Danilkovitch A., et al. . (2017). Antimicrobial peptides secreted from human cryopreserved viable amniotic membrane contribute to its antibacterial activity. Sci. Rep. 7:13722. 10.1038/s41598-017-13310-6 PubMed DOI PMC

Mcquilling J. P., Vines J. B., Kimmerling K. A., Mowry K. C. (2017). Proteomic comparison of amnion and chorion and evaluation of the effects of processing on placental membranes. Wounds 29, E36–E40. PubMed PMC

Mekkes J. R., Loots M. A., Van Der Wal A. C., Bos J. D. (2003). Causes, investigation and treatment of leg ulceration. Br. J. Dermatol. 148, 388–401. 10.1046/j.1365-2133.2003.05222.x PubMed DOI

Mohammadi A. A., Eskandari S., Johari H. G., Rajabnejad A. (2017). Using amniotic membrane as a novel method to reduce post-burn hypertrophic scar formation: a prospective follow-up study. J. Cutan. Aesthet. Surg. 10, 13–17. 10.4103/JCAS.JCAS_109_16 PubMed DOI PMC

Mohan R., Bajaj A., Gundappa M. (2017). Human amnion membrane: potential applications in oral and periodontal field. J. Int. Soc. Prev. Commun. Dent. 7, 15–21. 10.4103/jispcd.JISPCD_359_16 PubMed DOI PMC

Mrugala A., Sui A., Plummer M., Altman I., Papineau E., Frandsen D., et al. . (2016). Amniotic membrane is a potential regenerative option for chronic non-healing wounds: a report of five cases receiving dehydrated human amnion/chorion membrane allograft. Int. Wound J. 13, 485–492. 10.1111/iwj.12458 PubMed DOI PMC

Niknejad H., Peirovi H., Jorjani M., Ahmadiani A., Ghanavi J., Seifalian A. M. (2008). Properties of the amniotic membrane for potential use in tissue engineering. Eur. Cell. Mater. 15, 88–99. 10.22203/eCM.v015a07 PubMed DOI

Saap L. J., Donohue K., Falanga V. (2004). Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol. Surg. 30, 1095–1100. 10.1111/j.1524-4725.2004.30334.x PubMed DOI

Sabella N. (1913). Use of fetal membranes in skin grafting. Med. Rec. 83, 478–480.

Sheikh E. S., Sheikh E. S., Fetterolf D. E. (2014). Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds. Int. Wound J. 11, 711–717. 10.1111/iwj.12035 PubMed DOI PMC

Sippel K. C., Ma J. J., Foster C. S. (2001). Amniotic membrane surgery. Curr. Opin. Ophthalmol. 12, 269–281. 10.1097/00055735-200108000-00006 PubMed DOI

Smiell J. M., Treadwell T., Hahn H. D., Hermans M. H. (2015). Real-world experience with a decellularized dehydrated human amniotic membrane allograft. Wounds 27, 158–169. PubMed

Stern M. (1913). The grafting of preserved amniotic membrane to burned and ulcerated surfaces. Substituting Skin Grafts. JAMA 60, 973–974. 10.1001/jama.1913.04340130021008 DOI

Su Y. N., Zhao D. Y., Li Y. H., Yu T. Q., Sun H., Wu X. Y., et al. . (2020). Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: a systematic review and meta-analysis of randomised controlled trials. Int. Wound J. 17, 753–764. 10.1111/iwj.13318 PubMed DOI PMC

Tettelbach W., Cazzell S., Reyzelman A. M., Sigal F., Caporusso J. M., Agnew P. S. (2019). A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int. Wound J. 16, 19–29. 10.1111/iwj.12976 PubMed DOI PMC

Troensegaard-Hansen E. (1950). Amniotic grafts in chronic skin ulceration. Lancet 1, 859–860. 10.1016/S0140-6736(50)90693-3 PubMed DOI

Wang Z., Hasan R., Firwana B., Elraiyah T., Tsapas A., Prokop L., et al. . (2016). A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. J. Vasc. Surg. 63, 29S−36S.e2. 10.1016/j.jvs.2015.10.004 PubMed DOI

Werdin F., Tennenhaus M., Schaller H. E., Rennekampff H. O. (2009). Evidence-based management strategies for treatment of chronic wounds. Eplasty 9:e19. PubMed PMC

Zelen C. M. (2013). An evaluation of dehydrated human amniotic membrane allografts in patients with DFUs. J. Wound Care 22, 347–348, 350–341. 10.12968/jowc.2013.22.7.347 PubMed DOI

Zelen C. M., Serena T. E., Denoziere G., Fetterolf D. E. (2013). A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int. Wound J. 10, 502–507. 10.1111/iwj.12097 PubMed DOI PMC

Zelen C. M., Serena T. E., Gould L., Le L., Carter M. J., Keller J., et al. . (2016). Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost. Int. Wound J. 13, 272–282. 10.1111/iwj.12566 PubMed DOI PMC

Zelen C. M., Serena T. E., Snyder R. J. (2014). A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int. Wound J. 11, 122–128. 10.1111/iwj.12242 PubMed DOI PMC

Clinical Evaluation of AMNIODERM+® Wound Dressing Containing Non-Viable Human Amniotic Membrane: Retrospective-Perspective Clinical Trial